Literature DB >> 35014001

Morbidity and mortality in patients managed with high compared with low blood pressure targets during on-pump cardiac surgery: a systematic review and meta-analysis of randomized controlled trials.

Charlotte C McEwen1, Takhliq Amir2, Yuan Qiu2, Jack Young3, Kevin Kennedy4, Hilary P Grocott5, Hessam Kashani5, David Mazer6,7, Scott Brudney8, Morvarid Kavosh5, Eric Jacobsohn8, Anne Vedel9, Eugene Wang2, Richard P Whitlock10,11, Emilie P Belley-Coté11,12, Jessica Spence13,14.   

Abstract

PURPOSE: Many believe that blood pressure management during cardiac surgery is associated with postoperative outcomes. We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) to determine the impact of high compared with low intraoperative blood pressure targets on postoperative morbidity and mortality in adults undergoing cardiac surgery on cardiopulmonary bypass (CPB). Our primary objective was to inform the design of a future large RCT. SOURCE: We searched MEDLINE, EMBASE, Web of Science, CINAHL, and CENTRAL for RCTs comparing high with low intraoperative blood pressure targets in adult patients undergoing any cardiac surgical procedure on CPB. We screened reference lists, grey literature, and conference proceedings. PRINCIPAL
FINDINGS: We included eight RCTs (N =1,116 participants); all examined the effect of blood pressure management only during the CPB. Trial definitions of high compared with low blood pressure varied and, in some, there was a discrepancy between the target and achieved mean arterial pressure. We observed no difference in delirium, cognitive decline, stroke, acute kidney injury, or mortality between high and low blood pressure targets (very-low to low quality evidence). Higher blood pressure targets may have increased the risk of requiring a blood transfusion (three trials; n = 456 participants; relative risk, 1.4; 95% confidence interval, 1.1 to 1.9; P = 0.01; moderate quality evidence) but this finding was based on a small number of trials.
CONCLUSION: Individual trial definitions of high and low blood pressure targets varied, limiting inferences. The effect of high (compared with low) blood pressure targets on other morbidity and mortality after cardiac surgery remains unclear because of limitations with the body of existing evidence. Research to determine the optimal management of blood pressure during cardiac surgery is required. STUDY REGISTRATION: PROSPERO (CRD42020177376); registered: 5 July 2020.
© 2022. Canadian Anesthesiologists' Society.

Entities:  

Keywords:  Blood pressure targets; Cardiac surgery; Cardiopulmonary bypass; Morbidity and mortality

Mesh:

Year:  2022        PMID: 35014001     DOI: 10.1007/s12630-021-02171-3

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   6.713


  25 in total

1.  Intraoperative systolic blood pressure variability predicts 30-day mortality in aortocoronary bypass surgery patients.

Authors:  Solomon Aronson; Mark Stafford-Smith; Barbara Phillips-Bute; Andrew Shaw; Jeffrey Gaca; Mark Newman
Journal:  Anesthesiology       Date:  2010-08       Impact factor: 7.892

2.  Duration and magnitude of blood pressure below cerebral autoregulation threshold during cardiopulmonary bypass is associated with major morbidity and operative mortality.

Authors:  Masahiro Ono; Kenneth Brady; R Blaine Easley; Charles Brown; Michael Kraut; Rebecca F Gottesman; Charles W Hogue
Journal:  J Thorac Cardiovasc Surg       Date:  2013-09-26       Impact factor: 5.209

3.  Increased systemic perfusion pressure during cardiopulmonary bypass is associated with less early postoperative cognitive dysfunction and delirium.

Authors:  Matthias Siepe; Thomas Pfeiffer; Andreas Gieringer; Silke Zemann; Christoph Benk; Christian Schlensak; Friedhelm Beyersdorf
Journal:  Eur J Cardiothorac Surg       Date:  2010-12-18       Impact factor: 4.191

4.  Improvement of outcomes after coronary artery bypass II: a randomized trial comparing intraoperative high versus customized mean arterial pressure.

Authors:  Mary E Charlson; Janey C Peterson; Karl H Krieger; Gregg S Hartman; James P Hollenberg; William M Briggs; Alan Z Segal; Manish Parikh; Stephen J Thomas; Rebecca G Donahue; Mary Helen Purcell; Paul A Pirraglia; O Wayne Isom
Journal:  J Card Surg       Date:  2007 Nov-Dec       Impact factor: 1.620

Review 5.  Optimal perfusion during cardiopulmonary bypass: an evidence-based approach.

Authors:  Glenn S Murphy; Eugene A Hessel; Robert C Groom
Journal:  Anesth Analg       Date:  2009-05       Impact factor: 5.108

6.  High-Target Versus Low-Target Blood Pressure Management During Cardiopulmonary Bypass to Prevent Cerebral Injury in Cardiac Surgery Patients: A Randomized Controlled Trial.

Authors:  Anne G Vedel; Frederik Holmgaard; Lars S Rasmussen; Annika Langkilde; Olaf B Paulson; Theis Lange; Carsten Thomsen; Peter Skov Olsen; Hanne Berg Ravn; Jens C Nilsson
Journal:  Circulation       Date:  2018-01-16       Impact factor: 29.690

7.  How evidence based is English public health policy?

Authors:  Srinivasa Vittal Katikireddi; Martin Higgins; Lyndal Bond; Chris Bonell; Sally Macintyre
Journal:  BMJ       Date:  2011-11-17

8.  Determining Thresholds for Three Indices of Autoregulation to Identify the Lower Limit of Autoregulation During Cardiac Surgery.

Authors:  Xiuyun Liu; Kei Akiyoshi; Mitsunori Nakano; Ken Brady; Brian Bush; Rohan Nadkarni; Archana Venkataraman; Raymond C Koehler; Jennifer K Lee; Charles W Hogue; Marek Czosnyka; Peter Smielewski; Charles H Brown
Journal:  Crit Care Med       Date:  2021-04-01       Impact factor: 9.296

9.  All in the Family: systematic reviews, rapid reviews, scoping reviews, realist reviews, and more.

Authors:  David Moher; Lesley Stewart; Paul Shekelle
Journal:  Syst Rev       Date:  2015-12-22

10.  Decatecholaminisation during sepsis.

Authors:  Alain Rudiger; Mervyn Singer
Journal:  Crit Care       Date:  2016-10-04       Impact factor: 9.097

View more
  1 in total

Review 1.  Provisional Decision-Making for Perioperative Blood Pressure Management: A Narrative Review.

Authors:  Qiliang Song; Jipeng Li; Zongming Jiang
Journal:  Oxid Med Cell Longev       Date:  2022-07-11       Impact factor: 7.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.